A whole blood-based functional assay to characterize immunoglobulin A effector functions

Most investigations on the immune cell-activating potency of IgA used purified total IgA and/or specific isolated cell populations. As IgA2 has been reported to be more pro-inflammatory than IgA1, we aimed to employ a fast and convenient whole blood-based assay to individually probe the capacity of the two IgA subclasses to activate immune cells in close physiological conditions. To this end, whole blood from healthy donors (n = 10) was stimulated with immobilized IgA1, IgA2m1 or IgA2m2 (the two main allotypic variants of IgA2). Activation of major leukocyte subsets was measured using a 10-color flow cytometry panel providing access to the expression of 5 activation markers on 6 different immune cell subsets. While capturing some heterogeneity of responses among donors, IgA2m1 and IgA2m2 systematically showed a stronger activation profile compared to IgA1 in a variety of dimensions. For example, both IgA2 allotypes led to stronger modulations of CD54, CD11b, CD62L, CD66b or CD69, on both or either monocytes or neutrophils, indicating a more pronounced pro-inflammatory effect for this subclass than IgA1. By taking into account donor-specific soluble and cellular components this whole blood-based functional approach provides new perspectives to further investigate IgA effector functions in mechanistic studies and/or translational research.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:57

Enthalten in:

Autoimmunity - 57(2024), 1 vom: 31. Apr., Seite 2341629

Sprache:

Englisch

Beteiligte Personen:

Bacon, Alice [VerfasserIn]
Cartagena García, Celia [VerfasserIn]
van Schie, Karin A [VerfasserIn]
Toes, René E M [VerfasserIn]
Busnel, Jean-Marc [VerfasserIn]

Links:

Volltext

Themen:

Flow cytometry
Functional assay
IgA effector functions
IgA subclasses
Immunoglobulin A
Inflammation
Journal Article
Pre-clinical research
Whole blood

Anmerkungen:

Date Completed 16.04.2024

Date Revised 16.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/08916934.2024.2341629

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM37105902X